Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Dulanermin |
Synonyms | |
Therapy Description |
Dulanermin is a recombinant human Apo2L/Trail protein that potentially targets DR4 and DR5 to activate apoptotic pathways and reduce tumor growth (PMID: 29134432, PMID: 22914439). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Dulanermin | AMG951|AMG-951|AMG 951|RG3639 | Dulanermin is a recombinant human Apo2L/Trail protein that potentially targets DR4 and DR5 to activate apoptotic pathways and reduce tumor growth (PMID: 29134432, PMID: 22914439). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|